Greg Holgate is biocatalysis chemist with Sterling Pharma Solutions.
Seeking Economies of Scale for Biocatalysis
New enzymes and protein engineering have advanced biocatalysis processing toward commercial acceptance. Technology and economic roadblocks must be overcome for the process to be widely embraced by pharma.